C5 deficiency and C5a or C5aR blockade protects against cerebral malaria
Open Access
- 21 April 2008
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 205 (5), 1133-1143
- https://doi.org/10.1084/jem.20072248
Abstract
Experimental infection of mice with Plasmodium berghei ANKA (PbA) provides a powerful model to define genetic determinants that regulate the development of cereKeywords
This publication has 70 references indexed in Scilit:
- A Role for Natural Regulatory T Cells in the Pathogenesis of Experimental Cerebral MalariaThe American Journal of Pathology, 2007
- Genomic DNA functions as a universal external standard in quantitative real-time PCRNucleic Acids Research, 2006
- Conventional and experimental treatment of cerebral malariaInternational Journal for Parasitology, 2006
- Gene‐Expression Profiling Discriminates between Cerebral Malaria (CM)–Susceptible Mice and CM‐Resistant MiceThe Journal of Infectious Diseases, 2006
- Regulatory role of C5a in LPS‐induced IL‐6 production by neutrophils during sepsisThe FASEB Journal, 2003
- Anti-complement Strategies in Experimental SepsisScandinavian Journal of Infectious Diseases, 2003
- Association of a Determinant on Mouse Chromosome 18 with Experimental SeverePlasmodium bergheiMalariaInfection and Immunity, 2002
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001
- Mechanisms of Enhanced Lung Injury during SepsisThe American Journal of Pathology, 1999
- Role of cytokines and adhesion molecules in malaria immunopathologyThe International Journal of Cell Cloning, 1993